Article: Systemic therapies for metastatic castration resistant PCa

Here's a link to the full text of another article I received from Uroalerts:

Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology

There've been a few inquiries recently on the forum about options for some rather advanced metastatic cases. This article is from European Urology. It's a retrospective literature survey, not an actual study, so a lot of it may already be familiar to some here. For those in this situation, it may be a good succinct aggregation of some useful information.

From the article:
Introduction of novel agents for the management of advanced prostate cancer provides a range of treatment options with notable benefits for men with metastatic castration-resistant prostate cancer (mCRPC). At the same time, understanding of optimal patient selection, effective sequential use, and development of resistance patterns remains incomplete.

Evidence acquisition
A literature review of PubMed/Medline, Cochrane Library, Current Contents Medicine, Web of Science, Clinical Trial.Gov, WHO-ICTRP (January 2004–November 2017), and the proceedings of major international meetings (2015/2016/2017) was performed in November 2017.